Ana Marcia Guimaraes
@anamarciasg.bsky.social
Assistant Professor of Bacteriology at University of Sao Paulo, Brazil | Tuberculosis | One Health | Bioinformatics & Data Science | Wet Lab
Check out our new paper on the use of Fourier Transform Infrared Spectroscopy to differentiate between Mtb and M. bovis isolates . A 🧵👇🏽
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org
January 5, 2025 at 2:58 AM
Check out our new paper on the use of Fourier Transform Infrared Spectroscopy to differentiate between Mtb and M. bovis isolates . A 🧵👇🏽
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review - The Lancet Infectious Diseases
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review
We did a systematic review and meta-analysis of trials of treatment for rifampicin-susceptible
tuberculosis to evaluate the representativeness of participants compared with characteristics
of the glob...
www.thelancet.com
November 29, 2024 at 9:22 PM
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review - The Lancet Infectious Diseases
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial
www.thelancet.com/journals/lan...
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, o...
In this 14-day trial, quabodepistat plus delamanid plus bedaquiline, a novel three-drug
combination, appeared to be safe, well tolerated, and provided robust early bactericidal
activity in adults with...
www.thelancet.com
November 29, 2024 at 9:22 PM
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial
www.thelancet.com/journals/lan...
Reposted by Ana Marcia Guimaraes
If you're interested in learning about the latest of fundamental mycobacteriology, sign up for #GRCMyco2025! Acceptances will start in September, check out the full program and please RT!
We're live with the program!
www.grc.org/biology-of-m...
www.grc.org/biology-of-m...
May 16, 2024 at 11:36 PM
If you're interested in learning about the latest of fundamental mycobacteriology, sign up for #GRCMyco2025! Acceptances will start in September, check out the full program and please RT!